Carrier Screening Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

The global carrier screening market is anticipated to grow at a CAGR of 17.1% during the forecast period (2023-2030). Preconception, prenatal and population-based carrier screening are available to provide prospective and current parents with information about the risk of passing on genetic conditions to their offspring. Direct-to-Consumer (DTC) tests offer individuals an alternative to going through healthcare providers to obtain carrier screening results. High-risk populations or ethnic groups with a higher incidence of specific genetic disorders may be recommended to undergo screening. Furthermore, the market's growth is attributed to high carrier reliability and disease prevalence across the globe. Autosomal recessive conditions and X-linked conditions with carrier frequencies greater than 1/200 and disease prevalence greater than 1/40,000, respectively, have been selected for the panel due to their potential effects on public health, making it applicable to a variety of patients. For instance, in February 2023, Fulgent Genetics, Inc. launched the immediate availability of their new Beacon787 expanded carrier screening panel. Beacon787 is a gene panel that includes 787 genes associated with autosomal recessive and X-linked conditions. It includes all the American College of Medical Genetics and Genomics (ACMG) tier 3 genes recommended as a pan-ethnic screening approach for pregnant patients and those planning a pregnancy. This panel has genes with carrier frequency of >1/200 for autosomal recessive conditions and disease prevalence of >1/40,000 for X-linked conditions.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/carrier-screening-market

Furthermore, there is an increase in the number of individuals and couples who are interested in assessing their genetic risks for a variety of conditions in order to make informed decisions about family planning. in April 2019, SOFIVA GENOMICS, launched the new SOFIVA Carrier Scan Providing couples with technology to test for genetic diseases using next-generation sequencing and capillary electrophoresis. More than any other test now in use in the industry, SOFIVA Carrier Scan can screen for as numerous as 333 different diseases in a single test, including prevalent genetic diseases including Thalassemia, Spinal Muscular Atrophy, Fragile X Syndrome, and Glucose-6-Phosphate Dehydrogenase Deficiency.

Market Coverage

• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Type
o By Medical Condition
o By Technology
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Congenica Ltd, Illumina, Inc., Invitae Corp., Myriad Genetics, Inc., and Natera Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Carrier Screening Market Report Segment

By Type

• Expanded Carrier Screening
• Targeted Disease Carrier Screening

By Medical Condition

• Hematological
• Pulmonary
• Neurological
• Others (Familial Mediterranean Fever (FMF), and Fragile X Syndrome)

By Technology

• DNA Sequencing
• Polymerase Chain Reaction (PCR)
• Microarrays
• Others (Next-Generation Sequencing (NGS), Screened Conditions, and Direct-to-Consumer Testing)

By End User

• Hospitals and clinics
• Reference Laboratories
• Government and Public Health Programs
• Others (Pharmaceutical and Biotechnology Companies)

A full report of Carrier Screening Market available @ https://www.omrglobal.com/industry-reports/carrier-screening-market

Global Carrier Screening Market Report Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Ambry Genetics Corp.
• Cepheid
• Congenica Ltd.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Invitae Corp.
• Laboratory Corporation of America (Labcorp)
• MedGenome Inc
• Myriad Genetics, Inc.
• Natera Inc.
• PerkinElmer AES
• Quest Diagnostics Inc.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.